The goal of this prospective phase 2 study is to assess the efficacy and safety of intestinal or multivisceral transplantation for participants with PMP not am…

Secondary Malignant Neoplasm of RetroperitoneumSecondary Malignant Neoplasm of PeritoneumPseudomyxoma Peritonei

~Estimated

~$10 – $6,250

Case Comprehensive Cancer CenterNCT06084780

The ACPMP Research Foundation Appendix Cancer/PMP Patient Registry

ACPMP's first-ever patient-powered global patient registry/natural history study collects patient and caregiver information and data to fuel clinical trials an…

Appendix CancerPseudomyxoma Peritonei

~Estimated

~$10 – $750

Appendix Cancer Pseudomyxoma Peritonei Research FoundationNCT07769346

Phase 2

Use of Metformin in Patients With Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms

This is a pilot, open-label clinical trial determining the feasibility of metformin therapy in subjects with pseudomyxoma peritonei (PMP) secondary to appendic…

Appendiceal Mucinous NeoplasmPseudomyxoma Peritonei

~Estimated

~$10 – $6,250

University of California, IrvineNCT07693452